Virulence of serotype M3 group a streptococcus strains in wax worms (Galleria mellonella larvae)

Virulence

Volumn 2, Issue 2, 2011, Pages 111-119

  Olsen, Randall J ^a   Ebru Watkins, M ^a   Cantu, Concepcion C ^a   Beres, Stephen B ^a   Musser, James M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Galleria mellonella larvae; Group A streptococcus; Host pathogen interactions; Invasive infection; Invertebate model

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; GALLERIA MELLONELLA; GROUP A STREPTOCOCCAL INFECTION; HOST PATHOGEN INTERACTION; NONHUMAN; SEROTYPE; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; SURVIVAL; TISSUE INJURY; WORM; ANIMAL; CLASSIFICATION; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; ISOLATION AND PURIFICATION; LARVA; LD 50; LEPIDOPTERA; MICROBIOLOGY; PATHOGENICITY; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; VIRULENCE;

ANIMALIA; GALLERIA MELLONELLA; MUS; STREPTOCOCCUS SP. 'GROUP A'; VERTEBRATA;

BACTERIAL ANTIGEN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CARRIER STATE; GENOTYPE; HOST-PATHOGEN INTERACTIONS; HUMANS; LARVA; LEPIDOPTERA; LETHAL DOSE 50; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SURVIVAL ANALYSIS; VIRULENCE;

EID: 79952920986     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.2.14338     Document Type: Article

References (50)

1. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006; 103:8487-92.
2. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007; 104:9451-6.
3. Beres SB, Carroll RK, Shea PR, Sitkiewicz I, Martinez-Gutierrez JC, Low DE, et al. Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc Natl Acad Sci USA 2010; 107:4371-6.
4. Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, et al. Epidemic communityassociated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci USA 2008; 105:1327-32.
5. Beres SB, Richter EW, Nagiec MJ, Sumby P, Porcella SF, DeLeo FR, et al. Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci USA 2006; 103:7059-64.
6. Musser JM, DeLeo FR. Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. Am J Pathol 2005; 167:1461-72.
7. Olsen RJ, Musser JM. Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol 2010; 5:1-31.
8. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685-94.
9. Olsen RJ, Shelburne SA, Musser JM. Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol 2009; 11:1-12.
10. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335:547-54.
11. Li Z, Sakota V, Jackson D, Franklin AR, Beall B. Array of M protein gene subtypes in 1,064 recent invasive group A Streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis 2003; 188:1587-92.
12. Daneman N, Green KA, Low DE, Simor AE, Willey B, Schwartz B, et al. Surveillance for hospital outbreaks of invasive group A streptococcal infections in Ontario, Canada 1992 to 2000. Ann Intern Med 2007; 147:234-41.
13. Olsen RJ, Sitkiewicz I, Ayeras AA, Gonulal VE, Cantu C, Beres SB, et al. Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci USA 2010; 107:888-93.
14. Olsen RJ, Ashraf M, Gonulal VE, Ayeras AA, Cantu C, Shea PR, et al. Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus. Microb Pathog 2010; 49:336-47.
15. Kavanagh K, Reeves EP. Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens. FEMS Microbiol Rev 2004; 28:101-12.
16. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr, Mylonakis E. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53:2605-9.
17. Renwick J, Daly P, Reeves EP, Kavanagh K. Susceptibility of larvae of Galleria mellonella to infection by Aspergillus fumigatus is dependent upon stage of conidial germination. Mycopathologia 2006; 161:377-84.
18. Fedhila S, Daou N, Lereclus D, Nielsen-LeRoux C. Identification of Bacillus cereus internalin and other candidate virulence genes specifically induced during oral infection in insects. Mol Microbiol 2006; 62:339-55.
19. Seed KD, Dennis JJ. Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect Immun 2008; 76:1267-75.
20. Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of yeasts. FEMS Immunol Med Microbiol 2000; 27:163-9.
21. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73:3842-50.
22. Aperis G, Fuchs BB, Anderson CA, Warner JE, Calderwood SB, Mylonakis E. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect 2007; 9:729-34.
23. Mukherjee K, Altincicek B, Hain T, Domann E, Vilcinskas A, Chakraborty T. Galleria mellonella as a model system for studying Listeria pathogenesis. Appl Environ Microbiol 2010; 76:310-7.
24. Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 2000; 182:3843-5.
25. Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr, Eliopoulos GM. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 2009; 199:532-6.
26. Kobayashi SD, DeLeo FR. An update on communityassociated MRSA virulence. Curr Opin Pharmacol 2009; 9:545-51.
27. Smoot LM, Smoot JC, Graham MR, Somerville GA, Sturdevant DE, Migliaccio CA, et al. Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc Natl Acad Sci USA 2001; 98:10416-21.
28. Tojo S, Naganuma F, Arakawa K, Yokoo S. Involvement of both granular cells and plasmatocytes in phagocytic reactions in the greater wax moth, Galleria mellonella. J Insect Physiol 2000; 46:1129-35.
29. Soderhall K, Cerenius L. Role of the prophenoloxidaseactivating system in invertebrate immunity. Curr Opin Immunol 1998; 10:23-8.
30. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004; 305:1283-6.
31. Agniswamy J, Lei B, Musser JM, Sun PD. Insight of host immune evasion mediated by two variants of group A Streptococcus Mac protein. J Biol Chem 2004; 279:52789-96.
32. Sumby P, Zhang S, Whitney AR, Falugi F, Grandi G, Graviss EA, et al. A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun 2008; 76:978-85.
33. Beres SB, Sylva GL, Barbian KD, Lei B, Hoff JS, Mammarella ND, et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype and clone emergence. Proc Natl Acad Sci USA 2002; 99:10078-83.
34. Sitkiewicz I, Nagiec MJ, Sumby P, Butler SD, Cywes-Bentley C, Musser JM. Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc Natl Acad Sci USA 2006; 103:16009-14.
35. Johansson L, Thulin P, Sendi P, Hertzen E, Linder A, Akesson P, et al. LL-37 in severe Streptococcus pyogenes soft tissue infections. Infect Immun 2008; 76:3399-404.
36. Hollands A, Aziz RK, Kansal R, Kotb M, Nizet V, Walker MJ. A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS ONE 2008; 3:4102.
37. Shea PR, Virtaneva K, Kupko JJ, 3rd, Porcella SF, Barry WT, Wright FA, et al. Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus. Proc Natl Acad Sci USA 2010; 107:4693-8.
38. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, et al. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci USA 2005; 102:1679-84.
39. Sumby P, Tart AH, Musser JM. A non-human primate model of acute group A Streptococcus pharyngitis. Methods in Molecular Biology 2008; 431:255-67.
40. McIver KS. Stand-alone response regulators controlling global virulence networks in Streptococcus pyogenes. Contrib Microbiol 2009; 16:103-19.
41. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
42. Mehta S, McGeer A, Low DE, Hallett D, Bowman DJ, Grossman SL, et al. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest 2006; 130:1679-86.
43. Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, et al. Severe group A streptococcal softtissue infections in Ontario: 1992-1996. Clin Infect Dis 2002; 34:454-60.
44. Mereghetti L, Sitkiewicz I, Green NM, Musser JM. Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS ONE 2008; 3:2785.
45. Pandya U, Allen CA, Watson DA, Niesel DW. Global profiling of Streptococcus pneumoniae gene expression at different growth temperatures. Gene 2005; 360:45-54.
46. Voyich JM, Musser JM, DeLeo FR. Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens. Microbes Infect 2004; 6:1117-23.
47. Loughman JA, Caparon M. Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression. J Bacteriol 2006; 188:399-408.
48. Shelburne SA, Olsen RJ, Suber B, Sahasrabhojane P, Sumby P, Brennan RG, et al. A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection. PLoS Pathog 2010; 6:1000817.
49. Aziz RK, Kansal R, Aronow BJ, Taylor WL, Rowe SL, Kubal M, et al. Microevolution of group A streptococci in vivo: capturing regulatory networks engaged in sociomicrobiology, niche adaptation and hypervirulence. PLoS ONE 2010; 5:9798.
50. Hoe NP, Fullerton KE, Liu M, Peters JE, Gackstetter GD, Adams GJ, et al. Molecular genetic analysis of 675 Group A Streptococcus isolates collected in a carrier study at Lackland Air Force Base, San Antonio, Texas. J Infect Dis 2003; 188:818-27.